Norfloxacin

DRUG12 trials

Sponsors

Bayside Health, Unity Health Toronto, Assistance Publique - Hôpitaux de Paris, Insel Gruppe AG, University Hospital Bern, Eurofarma Laboratorios S.A.

Conditions

Adverse Reaction to Other Drugs and MedicinesAscitesCirrhosisCystitisHepatopulmonary SyndromeLiver CirrhosisPortal HypertensionSpontaneous Bacterial Peritonitis

Phase 2

A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome

CompletedNCT00362752

Unity Health TorontoHepatopulmonary Syndrome

Start: 2006-10-31End: 2009-12-31Updated: 2016-12-07

Phase 3

Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure

TerminatedNCT01037959

Assistance Publique - Hôpitaux de ParisCirrhosis

Start: 2010-04-30End: 2015-11-30Updated: 2015-12-09

Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)

WithdrawnNCT01527019

Eurofarma Laboratorios S.A.Cystitis

Start: 2012-10-31Updated: 2015-07-27

Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Sherief Abd-ElsalamAscites, Liver Cirrhosis, Spontaneous Bacterial Peritonitis

Start: 2014-01-31End: 2023-12-31Target: 100Updated: 2018-01-09

Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis

Ospedali Riuniti di FoggiaSpontaneous Bacterial Peritonitis

Start: 2019-11-05End: 2021-12-20Target: 322Updated: 2021-02-16

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

RecruitingNCT04161768

Tanta UniversitySpontaneous Bacterial Peritonitis

Start: 2018-12-01End: 2028-12-01Target: 80Updated: 2019-11-13

Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis

Tanta UniversitySpontaneous Bacterial Peritonitis

Start: 2021-03-31End: 2022-05-31Target: 60Updated: 2021-02-10

Phase 4

Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting.

TerminatedNCT01039545

Insel Gruppe AG, University Hospital BernUrinary Tract Infections

Start: 2012-02-29End: 2015-01-31Updated: 2015-07-09

Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention

CompletedNCT01542801

Korea UniversityAdverse Reaction to Other Drugs and Medicines

Start: 2011-08-31End: 2016-04-30Updated: 2016-12-28

Unknown Phase

Vasoactive Peptides in Portal Pressure

Bayside HealthPortal Hypertension

Updated: 2007-07-26

Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

CompletedNCT03702426

Institute of Liver and Biliary Sciences, IndiaSpontaneous Bacterial Peritonitis

Start: 2018-07-23End: 2019-07-31Updated: 2019-10-24

Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial)

Institute of Liver and Biliary Sciences, IndiaSpontaneous Bacterial Peritonitis

Start: 2024-01-05End: 2024-12-31Target: 280Updated: 2024-01-10

Related Papers

Norfloxacin with itopride versus norfloxacin alone in secondary prophylaxis of spontaneous bacterial peritonitis: a randomized trial

Egyptian Liver Journal2021-05-10

Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial

BMC Pulmonary Medicine2019-08-0621 citations

Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.

2018-08-23110 citations

Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial

BMJ2017-11-07171 citations